NasdaqGS - Delayed Quote USD

Integra LifeSciences Holdings Corporation (IART)

Compare
18.95 +0.07 (+0.37%)
At close: October 25 at 4:00 PM EDT
18.95 0.00 (0.00%)
After hours: October 25 at 4:02 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Stuart M. Essig Ph.D. Executive Chairman 152.5k -- 1962
Mr. Jan De Witte President, CEO & Director 888.67k -- 1964
Ms. Lea Daniels Knight Executive VP & CFO 673.15k -- 1972
Mr. Jeffrey A. Mosebrook Senior VP of Finance & Principal Accounting Officer 493.14k -- 1976
Mr. Eric Ian Schwartz Executive VP, Chief Legal Officer & Secretary 549.52k -- 1969
Mr. Robert T. Davis Jr. Executive VP & President of Tissue Technologies 529.05k 44.39k 1959
Mr. Michael J. McBreen Executive VP & President of Codman Specialty Surgical 611.28k -- 1967
Mr. Stephen Leonard Corporate VP of Global Operations & Supply Chain -- -- 1962
Laurene Isip Vice President of Global Corporate Communications & Public Relations -- -- --
Ms. Ruth L. Fleming Vice President of Global Marketing -- -- --

Integra LifeSciences Holdings Corporation

1100 Campus Road
Princeton, NJ 08540
United States
609 275 0500 https://www.integralife.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
3,946

Description

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Corporate Governance

Integra LifeSciences Holdings Corporation’s ISS Governance QualityScore as of October 1, 2024 is 1. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 1; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 4, 2024 at 1:30 PM UTC

Integra LifeSciences Holdings Corporation Earnings Date

Recent Events

September 6, 2024 at 2:45 PM UTC

at Morgan Stanley Global Healthcare Conference

September 4, 2024 at 5:30 PM UTC

at Wells Fargo Healthcare Conference

July 29, 2024 at 12:30 PM UTC

Q2 2024 Earnings Call

July 29, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 8, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

May 30, 2024 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 4, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

Related Tickers